Tappeiner, Christoph; Heinz, Carsten; Specker, Christof; Heiligenhaus, Arnd (2007). Rituximab as a treatment option for refractory endogenous anterior uveitis. Ophthalmic research, 39(3), pp. 184-186. Karger 10.1159/000103239
|
Text
103239.pdf - Published Version Available under License Publisher holds Copyright. Download (104kB) | Preview |
BACKGROUND
To report on anti-CD20 antibody therapy in a patient with uveitis refractive to immunosuppression therapy.
METHODS
Case report with ophthalmoscopic, optical coherence tomography and fluorescein-angiographic findings.
RESULTS
A 49-year-old woman was suffering from bilateral, noninfectious chronic anterior uveitis refractive to corticosteroids and immunosuppressive drugs. Bilateral visual acuity was 20/100 due to cataract and cystoid macular edema (CME). After treatment with rituximab, vision and CME improved, and uveitis was stable until the final visit (follow-up at 12 months).
CONCLUSION
The case report suggests that rituximab may be helpful for selected patients with chronic anterior uveitis refractive to corticosteroids and immunosuppressive medication.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology |
UniBE Contributor: |
Tappeiner, Christoph |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0030-3747 |
Publisher: |
Karger |
Language: |
English |
Submitter: |
Christoph Tappeiner |
Date Deposited: |
04 Mar 2014 10:06 |
Last Modified: |
21 Sep 2023 10:11 |
Publisher DOI: |
10.1159/000103239 |
PubMed ID: |
17534119 |
BORIS DOI: |
10.7892/boris.42894 |
URI: |
https://boris.unibe.ch/id/eprint/42894 |
Actions (login required)
 |
Edit item |